Brainstorm Cell Therapeutics Inc. Stock

Market capitalization is the stock price multiplied by the number of shares issued.

Brainstorm Cell Therapeutics Inc.

Enterprise value (EV) is a measure of the value of a company regardless of its financing. It is calculated as follows:
EV = market capitalization - cash + debt.

Enterprise Value metric explained

Brainstorm Cell Therapeutics Inc.

Cash is defined as cash and cash equivalents (i.e. cash items of very high value).

Brainstorm Cell Therapeutics Inc.

The P/E ratio or price/earnings ratio TTM (Trailing Twelve Months) over the last 12 months describes the ratio of the stock price to earnings per share.

Brainstorm Cell Therapeutics Inc.

If you divide the enterprise value by the Free Cash Flow of the last 12 months, you obtain an important metric for assessing the valuation of companies - even if they are not yet generating profits.

Brainstorm Cell Therapeutics Inc.

The P/B ratio TTM (Trailing Twelve Months) over the last 12 months describes the ratio of the stock price to the book value per share.

Brainstorm Cell Therapeutics Inc.

Revenue TTM (Trailing Twelve Months) represents the sum of all revenues of a company for its products, services or other items within the last 12 months.

Brainstorm Cell Therapeutics Inc.

EBIT or the operating result represents the profit or loss after deducting direct costs (cost of sales), sales, marketing, administrative, research and development costs and depreciation and amortization.

Brainstorm Cell Therapeutics Inc.

Free Cash Flow TTM (Trailing Twelve Months) provides information on how much of the profit generated over the last 12 months remains in the company's coffers and is therefore available for profit distributions, share buybacks or debt repayment.

Brainstorm Cell Therapeutics Inc.